One specific mechanism by which VEGF contributes to the immunosuppression of NSCLC is by mediating tumour microangiogenesis and activating antigen-presenting cells, regulatory T-cells (Treg), and tumour-associated macrophages. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.